People: Allergan Inc (AGN.N)

AGN.N on New York Stock Exchange

163.68USD
29 Aug 2014
Price Change (% chg)

$1.57 (+0.97%)
Prev Close
$162.11
Open
$162.97
Day's High
$163.95
Day's Low
$161.97
Volume
154,331
Avg. Vol
321,710
52-wk High
$174.48
52-wk Low
$86.96

Search Stocks

Ray, Russell 

Brief Biography

Mr. Russell T. Ray is Independent Director of Allergan Inc. He has served as a Partner of HLM Venture Partners, a private equity firm that provides venture capital to health care information technology, health care services and medical technology companies, since September 2003. Mr. Ray was Founder, Managing Director and President of Chesapeake Strategic Advisors, a firm specializing in providing advisory services to health care and life sciences companies, from April 2002 to August 2003. From June 1999 to March 2002, Mr. Ray was Managing Director and Global Co-Head of the Credit Suisse First Boston Health Care Investment Banking Group, where he focused on providing strategic and financial advice to life sciences, health care services and medical device companies. Prior to joining Credit Suisse First Boston, Mr. Ray spent 12 years at Deutsche Bank, and its predecessor entities BT Alex. Brown and Alex. Brown & Sons, Inc., most recently as Global Head of Health Care Investment Banking. Mr. Ray is a Director of Prism Education Group, Inc., a closely-held post secondary career education company and SWP Media, Inc., a closely-held distributor of digital content. Mr. Ray served as a director of InfoMedics, Inc., a closely-held healthcare information technology company, from December 2009 through December 2012 when the company was acquired. Mr. Ray is also a director of the Midwest Peregrine Society. Mr. Ray is a former director of Socios Mayores en Salud. Mr. Ray was elected to Board in April 2003, is Chairman of the Audit and Finance Committee and is a member of the Organization and Compensation Committee.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Pyott

12,029,300

Douglas Ingram

3,576,040

James Hindman

--

Scott Whitcup

2,913,090

Arnold Pinkston

--

Scott Sherman

--
As Of 30 Dec 2013
Search Stocks